While the oncogenic function of TRPML1, the main driver of TFEB activation in healthy cells, remains obscure, TPC1 and TPC2 are standing out as crucial drivers of many cancer hallmarks, including excessive proliferation, aberrant migration and sustained vascularization. The gene discussed is TFEB; the disease is cancer.